Skip to main content

nl
fr
en

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Notification of adverse reactions or incidents

Home
Human medicines
Particular products
Specially reglemented substances
Precursors
Legislation - Background

Legislation - Background

Under construction.

Last updated on 16/12/2008

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

16/11/2018

Update on the new Clinical Trial Regulation pilot project 16.11.2018

16/11/2018

Publication of the update of the Guidance for submission of CTA initial dossiers, substantial amendments and end of trial notifications to the Research and Development Division (human use) of the FAMHP. 16.11.2018

16/11/2018

Antibiotic Awareness Week: working together to reduce anti-microbial resistance.

09/11/2018

PRAC October 2018 – Recommendation to restrict the use of fluoroquinolone and quinolone antibiotics

All news

© 2016 - FAMHP

Site map
Disclaimer
Complaints
Contact